Clinical trial
Study of T900607-Sodium in Previously Treated Patients With Ovarian Cancer.
NCT00043446 · Tularik, Industry · Unknown status
Key facts
| NCT number | NCT00043446 |
|---|---|
| Title | Study of T900607-Sodium in Previously Treated Patients With Ovarian Cancer. |
| Lead sponsor | Tularik, Industry |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Ovarian Neoplasms |
| Intervention type | Drug |
| Interventions | intravenous T900607-sodium |
| Enrollment | 35 |
| Start date | Jul 1, 2002 |
| First posted | Aug 12, 2002 |
| Last update posted | Jun 24, 2005 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: